WBB Securities Initiates Coverage on Electro-Optical Sciences (MELA) with a Sell
More News related to MELA
- Electro-Optical Sciences Appoints Charles Stiefel to Board of Directors
- Morning Movers 11/30: PEIX, CLRT, PROV, SOMX, OTIV Higher; HPOL, MELA Lower
- WBB Securities Initiates Coverage on Electro-Optical Sciences (MELA) with a Sell
- Boenning & Scattergood Initiates Coverage on Electro-Optical Sciences (MELA) with an Outperform
- Roth Capital Downgrades Electro-Optical Sciences (MELA) to Hold; Valuation Call
More News related to New Coverage
- Caris & Co Initiates Coverage on Express Scripts (ESRX) with a Buy
- Canaccord Adams Initiates Coverage on Swift Energy (SFY) with a Buy; Legacy Assets Providing a Launch Pad
- Canaccord Adams Initiates Coverage on Gastar Exploration (GST) with a Buy; Digging Deep for Returns
- Caris & Co Initiates Coverage on Medco Health Solutions (MHS) with an Above Average
- Brigantine Advisors Initiates Coverage on Align Technology (ALGN) with a Buy; Anticipate Strong Growth from Orthodontic Channel
WBB Securities initiates coverage on Electro-Optical Sciences (Nasdaq: MELA) with a Sell rating. Price target $7.25.
To see all the upgrades/downgrades on shares of MELA, visit our Analyst Ratings page.
Electro-Optical Sciences, Inc., a medical device company, focuses on the design, development, and commercialization of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma in the United States and internationally.
Related Categories
New CoverageStocks Mentioned
-0.02Comments View All Comments
watch your profits
if he does not announce at least a panel meeting, protect your profits
possible reason for wbb sell rating
on nov. 30 price of mela was approx $10.80 mark. We are there again w/o an approval. set your stops if your a trader. ignore if you an investor.
for traders of Mela
Protect your gains around the 10.80 mark. this should be close to the new post approval value of $12 set a few months ago. 2mil additional shares have since been issued to Knightsbridge Capital adjusting new value down %10 or $1.20 to $10.80.
INSANE
HOw on earth can they issue a sell rateing a couple of months from the FDA decision ? Do they know something or is it just a cool call??
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
expedited review process drawing down
ten on Jan 21, 2010 10:45 AMcan someone clarify if the expedited review process is up on Feb. 4? From my count this is 6 months after acceptance on Aug 4.